Want to see IN:MAXHEALTH full AI Analyst Report?
MAXHEALTH Stock Chart & Stats
₹1202.35
₹4.85(0.40%)
At close: 4:00 PM EST
₹1202.35
₹4.85(0.40%)
Day’s Range― - ―
52-Week Range₹903.50 - ₹1,301.95
Previous CloseN/A
Volume2.66M
Average Volume (3M)80.22K
Market Cap
₹1.08T
Enterprise Value₹1.03T
Total Cash (Recent Filing)₹7.01B
Total Debt (Recent Filing)₹34.78B
Price to Earnings (P/E)73.7
Beta1.18
Next Earnings
Aug 11, 2026EPS Estimate
4.07Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)14.83
Shares Outstanding973,243,800
10 Day Avg. Volume58,776
30 Day Avg. Volume80,220
Financial Highlights & Ratios
PEG Ratio1.90
Price to Book (P/B)8.67
Price to Sales (P/S)11.13
P/FCF Ratio626.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)19.91
Revenue Forecast (FY)₹120.11B
Bulls Say, Bears Say
Bulls Say
Revenue Growth / ScaleSustained multi-year revenue expansion and positive growth into 2026 indicate durable demand and successful network expansion. A larger hospital footprint and diversified specialty care improve utilization and provide a stable base to fund incremental investments and operating leverage over the medium term.
Operating ProfitabilityImproved gross margins and consistent operating profitability reflect underlying service mix and pricing power in higher-acuity specialties. Sustained operating margins support reinvestment, specialist recruitment, and margin recovery initiatives, helping preserve earnings quality over the next several quarters.
Balance Sheet / Equity BaseA strong and growing equity base plus improving ROE after prior losses provides financial resilience and capacity to invest in capacity or acquisitions. Historically moderate leverage gives flexibility to absorb shocks and fund strategic expansion without immediate refinancing pressure.
Bears Say
Rising LeverageA notable step-up in debt in 2026 materially raises interest expense and refinancing risk versus the prior low-leverage profile. Higher leverage constrains capital allocation, reduces flexibility for opportunistic investments or dividends, and increases sensitivity to rising rates over the medium term.
Weak/Volatile Free Cash FlowDeteriorating and volatile free cash flow — with OCF covering ~80% of net income and FCF ~34% of net income in 2025 — limits internal funding for capex, debt paydown, and growth. Persistent weak cash conversion raises reliance on external financing and heightens funding risk.
Margin Pressure / Profitability TrendA downward trend in net margins and reduced operating profit in 2026 suggest cost or case-mix pressures that could persist. Sustained margin erosion would weaken return on invested capital, reduce free cash generation and constrain the company’s ability to sustain investment and service higher debt.
Max Healthcare Institute Ltd News
MAXHEALTH FAQ
What was Max Healthcare Institute Ltd’s price range in the past 12 months?
Max Healthcare Institute Ltd lowest stock price was ₹903.50 and its highest was ₹1301.95 in the past 12 months.
What is Max Healthcare Institute Ltd’s market cap?
Max Healthcare Institute Ltd’s market cap is ₹1.08T.
When is Max Healthcare Institute Ltd’s upcoming earnings report date?
Max Healthcare Institute Ltd’s upcoming earnings report date is Aug 11, 2026 which is in 27 days.
How were Max Healthcare Institute Ltd’s earnings last quarter?
Max Healthcare Institute Ltd released its earnings results on May 21, 2026. The company reported ₹3.5 earnings per share for the quarter, missing the consensus estimate of ₹4.155 by -₹0.655.
Is Max Healthcare Institute Ltd overvalued?
According to Wall Street analysts Max Healthcare Institute Ltd’s price is currently Overvalued.
Does Max Healthcare Institute Ltd pay dividends?
Max Healthcare Institute Ltd pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.14%. See more information on Max Healthcare Institute Ltd dividends here
What is Max Healthcare Institute Ltd’s EPS estimate?
Max Healthcare Institute Ltd’s EPS estimate is 4.07.
How many shares outstanding does Max Healthcare Institute Ltd have?
Max Healthcare Institute Ltd has 973,243,800 shares outstanding.
What happened to Max Healthcare Institute Ltd’s price movement after its last earnings report?
Max Healthcare Institute Ltd reported an EPS of ₹3.5 in its last earnings report, missing expectations of ₹4.155. Following the earnings report the stock price went up 1.417%.
Which hedge fund is a major shareholder of Max Healthcare Institute Ltd?
Currently, no hedge funds are holding shares in IN:MAXHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Max Healthcare Institute Ltd
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―